Indication

Complicated skin and skin structure Staphylococcus aureus infection

A complicated skin and skin structure *Staphylococcus aureus* infection is a severe, deep-tissue bacterial infection of the integumentary system caused by methicillin-susceptible or methicillin-resistant strains of *Staphylococcus aureus*. Read more about Complicated skin and skin structure Staphylococcus aureus infection

232 drugs 131 manufacturers

Advertisement

Drugs that treat it

Common Complicated skin and skin structure Staphylococcus aureus infection therapies.

Showing 217–225 of 232 drugs

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
TEVA PHARM

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
FRESENIUS KABI

DALBAVANCIN HCL

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·COMPLICATED SKIN AND SKIN STRUCTURE STAPHYLOCOCCUS AUREUS INFECTION·+6
MEITHEAL PHARMA

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS·STAPHYLOCOCCUS AUREUS SEPTICEMIA·+6
Endo USA
Filter & compare in the drug finder →Opens the drug finder with Complicated skin and skin structure Staphylococcus aureus infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Complicated skin and skin structure Staphylococcus aureus infection.

A complicated skin and skin structure *Staphylococcus aureus* infection is a severe, deep-tissue bacterial infection of the integumentary system caused by methicillin-susceptible or methicillin-resistant strains of *Staphylococcus aureus*.

It involves deeper anatomical layers such as the deep dermis, subcutaneous tissue, fascia, or underlying musculature, frequently manifesting as extensive cellulitis, major cutaneous abscesses, infected ulcers, or surgical wound infections.

This clinical state typically arises when *S.

aureus* invades compromised tissue, causing acute purulent inflammation, significant erythema, induration, and tissue destruction, often accompanied by systemic symptoms such as fever or leukocytosis.

It predominantly affects hospitalized patients or individuals with predisposing comorbidities—such as diabetes mellitus, peripheral vascular disease, or immunosuppression—and commonly necessitates procedural or surgical intervention alongside systemic antimicrobial therapy.

Personalize your experience

Follow Complicated skin and skin structure Staphylococcus aureus infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it